Advanced Biomed Inc. 8-K

What Happened
Advanced Biomed Inc. filed an 8-K (Jan 27, 2026) disclosing a Supplemental Agreement (dated Jan 26, 2026) related to a December 23, 2025 Spin-Off Agreement to sell 100% of Advanced Biomed (HK) Limited to Wei Ha Hui for US$23,000. Under the Supplemental Agreement, Advanced Biomed (HK) Limited acknowledges it owes the parent company $6,925,549 (reflecting accounts receivable) and irrevocably agrees to repay that Debt in full on or before the first anniversary of the Supplemental Agreement (by Jan 26, 2027). The company’s board unanimously approved the Supplemental Agreement.

Key Details

• Buyer: Wei Ha Hui (unrelated third party); original sale price for Advanced Biomed (HK) Limited: US$23,000 (Spin-Off Agreement dated Dec 23, 2025).
• Debt acknowledged by Advanced Biomed (HK) Ltd.: $6,925,549 (accounts receivable as of the Spin-Off and Supplemental Agreement dates).
• Repayment deadline: on or before the first anniversary of the Supplemental Agreement (Jan 26, 2027).
• Board action: Supplemental Agreement and transaction were unanimously approved by the company’s board.

Why It Matters
This filing documents that the Hong Kong subsidiary was sold for a nominal cash price while a significant receivable (nearly $6.93M) remains owed to the parent and is now contractually required to be repaid within a year. For investors, the repayment obligation is the primary remaining economic interest tied to the disposition of the HK unit and could affect the company’s reported receivables, liquidity, and cash flow depending on collectability and timing. The board’s unanimous approval indicates corporate authorization of the amended terms.